PRIVIGEN

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug PRIVIGEN contains one active pharmaceutical ingredient (API):

1 Immunoglobulins, normal human, IV UNII RX2MM64U68 - HUMAN IMMUNOGLOBULINS

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02304619
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 103-MBE-0617
Country: EE	Ravimiamet	Identifier(s): 1364228, 1364239, 1364240, 1462418, 1462429, 1462430, 1668326
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08446001, 08446002, 08446003, 08446004, 108446007
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 034401, 126684, 126695, 126707, 544385
Country: FR	Base de données publique des médicaments	Identifier(s): 62946452
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 151462, 151465, 151469, 155458
Country: HK	Department of Health Drug Office	Identifier(s): 62854, 62855, 62856, 63836
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7137, 7138
Country: IT	Agenzia del Farmaco	Identifier(s): 039712017, 039712029, 039712031, 039712043, 039712056, 039712068, 039712070
Country: JP	医薬品医療機器総合機構	Identifier(s): 6343427A7020, 6343427A7038, 6343427A8026, 6343427A8034, 6343427A9022, 6343427A9030, 6343427H1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1032834, 1032835, 1032836, 1056687, 1056688, 1056689, 1071804
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 135658, 80047, 80055, 80063, 80071
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14649
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100214904
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W53030001, W53030002, W53030003, W53030004, W53030005
Country: SG	Health Sciences Authority	Identifier(s): 15574P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13813021H, 13813022H, 13813023H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681624980149, 8681624980156, 8681624980163
Country: US	FDA, National Drug Code	Identifier(s): 44206-436, 44206-437, 44206-438, 44206-439